Cimzia (certolizumab) is a prescription drug used to treat plaque psoriasis, Crohn’s disease, and some types of arthritis, including rheumatoid arthritis. It’s given as an injection under the skin.

The Food and Drug Administration (FDA) has approved Cimzia to treat certain inflammatory conditions in adults, including rheumatoid arthritis. It’s also FDA approved for polyarticular juvenile ...

How Do I Use Cimzia? Cimzia is a liquid that is injected under the skin every 2 to 4 weeks. The dose and how often you use the medication will be determined by your health care provider. It can be ...

Each of these conditions causes your immune system (the body’s defense against disease) to mistakenly attack healthy cells. Cimzia and Humira help prevent the immune system from doing this. The drugs ...

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial ...

May 27, 2009 — The US Food and Drug Administration (FDA) has approved risperidone long-acting injection for use alone or with lithium or valproate in the treatment of bipolar I disorder; and ...

Cimzia (certolizumab) is a prescription drug used to treat some types of arthritis and other conditions. Cimzia can cause side effects that range from mild to serious. Examples include infection and ...

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion from the EMA. UCB developed the AutoClicks ...

* EMA has recommended the Cimzia dose dispenser cartridge for use with the re-usable ava electronic injection device in all approved indications Source text: bit.ly/2qcXlVg Further company coverage: ...

UCB (UCB.BR) The European marketing authorisation application for Cimzia® has been filed. Subject to approval, Cimzia® will be the first and only PEGylated, Fc-Free anti-TNF (Tumour Necrosis Factor ...

BARCELONA, June 14 (Reuters) - UCB SA's experimental arthritis treatment Cimzia could be priced at a discount to rivals, since the drug has lower production costs, a key scientific investigator on the ...

WASHINGTON The Food and Drug Administration today approved Cimzia, a new drug by UCB to treat Crohn’s disease. Crohn’s disease is a chronic, inflammatory bowel disease. It has no cure and its cause is ...